| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 05/15/2008 | WO2008055959A1 Novel compounds useful for the treatment of degenerative & inflammatory diseases |
| 05/15/2008 | WO2008033798A3 A pyrrolopyrazin as syk-kinase inhibitor |
| 05/15/2008 | US20080114458 Intervertebral disc treatment devices and methods |
| 05/15/2008 | US20080114079 TRPM2-specfic inhibitors |
| 05/15/2008 | US20080114051 Pyrrolidine derivatives as prostaglandin modulators |
| 05/15/2008 | US20080114042 Compound |
| 05/15/2008 | US20080114006 For example, 1-(5-(2-amino-8-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)-2-fluorophenyl)-3-(3-tert-butyl-1-phenyl-1H-pyrazol-5-yl)urea; for treatment of mammalian cancers and inflammatory diseases including rheumatoid arthritis, retinopathies |
| 05/15/2008 | US20080114004 Hydrazone derivatives as kinase inhibitors |
| 05/15/2008 | US20080113997 Compounds, compositions, processes of making, and methods of use related to inhibiting macrophage migration inhibitory factor |
| 05/15/2008 | US20080113989 For example, N-(1-Carbamoyl-1-oxo-3-phenylpropan-2-yl)-2-(E-2-(4-(1-pyrrolidinylmethyl)phenyl)ethen-1-yl)benzamide; calcium channel blockers; cardiovascular disorders; antiarthritic agents; inhibitors of enzymes, especially cysteine proteases such as calpain and cathepsins |
| 05/15/2008 | US20080113973 Pharmaceutical composition in unit dose form which contains a COX-2 inhibitor and a thromboxane A2 receptor antagonist; for treatment of pain or inflammation; less risk of inducing adverse cardiovascular effects than when COX-2 inhibitors are administered alone |
| 05/15/2008 | US20080113965 Skeletal muscle protecting agent |
| 05/15/2008 | US20080113959 {Beta}-Lactamyl vasopression V1a antagonists and methods of use |
| 05/15/2008 | US20080113428 Novel Polypeptide Hormone Phosphatonin |
| 05/15/2008 | US20080113346 Using allelic variation in uncoupling gene (UCP2/UCP3)sequences as rheumatoid arthritis diagnostic |
| 05/15/2008 | US20080113038 a synergystic mixture of beta -cryptoxanthin and zinc compound such as elemental zinc, zinc sulfate, zinc chloride or zinc gluconate, used for prevention or therapy of bone disorders; osteoporosis |
| 05/15/2008 | US20080112996 Bone cell delivery device |
| 05/15/2008 | US20080112936 Methods of implanting mesenchymal stem cells for tissue repair and formation |
| 05/15/2008 | US20080112918 Method for treating gout and binding uric acid |
| 05/14/2008 | EP1921133A2 System for processing lipoaspirate cells |
| 05/14/2008 | EP1921078A1 Multikinase inhibitor |
| 05/14/2008 | EP1920780A1 Peptide compounds for the treatment of hyperexcitability disorders |
| 05/14/2008 | EP1920773A1 Compositions for inhibition of anglogenesis |
| 05/14/2008 | EP1919979A1 Polymer conjugates of k-252a and derivatives thereof |
| 05/14/2008 | EP1919914A2 P38 map kinase inhibitors and methods for using the same |
| 05/14/2008 | EP1919505A2 Single dose use of cd20-specific binding molecules |
| 05/14/2008 | EP1664013B1 Calcilytic compounds |
| 05/14/2008 | EP1660184A4 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 05/14/2008 | EP1465900B1 Rho-kinase inhibitors |
| 05/14/2008 | EP1309355B1 Peptide and peptide mimetic conjugates with integrin-inhibitor properties |
| 05/14/2008 | EP1235934B1 Screening method for candidate drugs |
| 05/14/2008 | CN101180047A Use of cyclodextrin complexes containing lipoic acid |
| 05/14/2008 | CN101176766A Traditional chinese medicine medicament for curing femoral head necrosis |
| 05/14/2008 | CN101176736A Medicine gas for curing rheumatism |
| 05/14/2008 | CN101176732A Hydrochloric acid glucosamine dispersible tablet and preparation method thereof |
| 05/14/2008 | CN100387724C Method for preparing extract of sophorae fructus containing high concentration of aglycone by hot water extraction |
| 05/14/2008 | CN100387713C Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAs encoding the same |
| 05/14/2008 | CN100387295C Wanhua oil Babu plaster for traumatic injury and preparing method |
| 05/14/2008 | CN100387277C Preparation method of notoginseng-containing tablet for treating traumatic injury |
| 05/14/2008 | CN100387276C Bone-activating ointment |
| 05/14/2008 | CN100387257C Chinese medicine for treating fractures and processing technology thereof |
| 05/14/2008 | CN100387251C Film coated tablet for bone injury and preparation process thereof |
| 05/14/2008 | CN100387248C Bone consumption powdered injection preparation |
| 05/14/2008 | CN100387244C Composition for anti osteo porosis |
| 05/14/2008 | CN100387242C American ginseng and royal jelly soft capsule |
| 05/14/2008 | CN100387231C Process for preparing colatemo solid preparation and its solid preparation |
| 05/13/2008 | US7371820 Nutraceuticals for the treatment, protection and restoration of connective tissues |
| 05/13/2008 | US7371819 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 05/13/2008 | US7371779 Synergistic compositions of N-acylhomoserine lactones and 4-quinolones |
| 05/13/2008 | US7371777 Such as 2-(3-{[(4-ethoxybenzoyl)amino]methyl}-4-ethoxybenzyl)-tetrahydro-2-furancarboxylic acid; antihyperglycemia and antihyperlipemia action |
| 05/13/2008 | US7371754 Tyrosine kinase inhibitors |
| 05/13/2008 | US7371747 Cyanoalkylamino derivatives as protease inhibitors |
| 05/13/2008 | US7371744 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents |
| 05/13/2008 | US7371735 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 05/13/2008 | US7371725 Spondyloarthropathies |
| 05/13/2008 | US7371723 Therapeutic agents comprising pro-apoptotic proteins |
| 05/13/2008 | US7371574 Antibody antagonists of VE-cadherin without adverse effects on vascular permeability |
| 05/13/2008 | US7371535 Detect binding with cells transfected with DNA |
| 05/13/2008 | US7371383 Genetic enginieered mixtures of complementary determining regions(CDR) antigens used for analyzing neutralizing epitopes and for prophylaxis of allergies and respiratory system disorders |
| 05/13/2008 | US7371382 Grafting antibodies to nucleic acids; anticancer agents, osteoporosis, vision defects, antiinflammatory agents, skin disorders |
| 05/13/2008 | US7371377 Bone morpogenic proteins; endothelial growth factor e (vegfe); wound healing agents; tissue engineering; bradycardial agents |
| 05/13/2008 | CA2437814C Human monoclonal antibodies to fc alpha receptor (cd89) |
| 05/13/2008 | CA2410234C 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl in pure crystalline form and process for synthesis |
| 05/13/2008 | CA2344222C Adhesive protein foam for surgical and/or therapeutic uses |
| 05/13/2008 | CA2283326C An aqueous metal bicarbonate solution and method of use |
| 05/13/2008 | CA2279939C Treatment and prevention of adhesions |
| 05/13/2008 | CA2255856C Therapeutic uses for an aminosterol compound |
| 05/13/2008 | CA2235298C Isoxazole derivatives |
| 05/13/2008 | CA2184916C Use of fibroblast growth factors to stimulate bone growth |
| 05/08/2008 | WO2008054756A2 Sesquiterpene lactones from artemisia leucodes as anti-inflammatory and gene regulators |
| 05/08/2008 | WO2008054594A2 Method for controlling angiogenesis in animals |
| 05/08/2008 | WO2008053913A1 Sulfonylurea derivative capable of selectively inhibiting mmp-13 |
| 05/08/2008 | WO2008053892A1 Pharmaceutical for promoting functional regeneration of damaged tissue |
| 05/08/2008 | WO2008053861A1 Novel compound having 1,4-benzoxazin-3-one skeleton |
| 05/08/2008 | WO2008053131A1 Hydroxamates as inhibitors of histone deacetylase |
| 05/08/2008 | WO2008052734A1 Heterocyclic compounds as antiinflammatory agents |
| 05/08/2008 | WO2007146138A3 Thiadiazole compounds and methods of use thereof |
| 05/08/2008 | WO2007139887A3 Methods for treating bone or joint inflammation |
| 05/08/2008 | US20080108808 Dipeptidyl peptidase inhibitors |
| 05/08/2008 | US20080108807 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile |
| 05/08/2008 | US20080108696 Phytoestrogenic Formulations for Alleviation or Prevention of Neurodegenerative Diseases |
| 05/08/2008 | US20080108661 N-{3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]-2-hydroxypropyl}-2,3-dihydro-2-oxo-4-(trifluoromethyl)-5-thiazolecarboxamide; chemokine receptor CCR3 modulator and histamin receptor H1 antagonist; antiinflammatory agent, antiallergen; asthma, rhinitis, COPD, osteoarthritis or osteoarthrosis |
| 05/08/2008 | US20080108658 Methods of promoting osteogenesis |
| 05/08/2008 | US20080108648 Novel imidazo[1,5-a] pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 05/08/2008 | US20080108647 Treatment of HIV and diseases of immune dysregulation |
| 05/08/2008 | US20080108641 Compounds for treating inflammatory disorders, demyelinating disdorders and cancers |
| 05/08/2008 | US20080108590 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickenier; extended time high blood serum concentration; rapidly absorbed gel |
| 05/08/2008 | US20080108588 NO-alendronate; NO-pamidronate; NO-clodronate; NO-risedronate; NO-zolendronate; NO-etidronate; NO-ibandronate; NO-tiludronate; NO-neridronate; NO-olpadronate; NO-icadronate; NO-YH529; additional agent such as growth hormones, bone morphogenic proteins enhances bone growth or decreases bone resorption |
| 05/08/2008 | US20080108587 Cartilage regeneration promoting agent |
| 05/08/2008 | US20080108566 Analogues of GLP-1 |
| 05/08/2008 | US20080108086 Parathyroid hormone antagonists and uses thereof |
| 05/08/2008 | US20080107627 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 05/08/2008 | US20080107597 Isolation of antibodies that cross-react and neutralize rankl originating from multiple species |
| 05/08/2008 | DE202008002263U1 Gesundheitsförderndes Mittel und dessen Verwendung Health-promoting agent and its use |
| 05/08/2008 | CA2668070A1 Hydroxamates as inhibitors of histone deacetylase |
| 05/08/2008 | CA2667962A1 Heterocyclic compounds as antiinflammatory agents |
| 05/08/2008 | CA2636788A1 Pharmaceuticals that promote functional regeneration of damaged tissues |
| 05/07/2008 | EP1918377A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 05/07/2008 | EP1918278A1 Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases |
| 05/07/2008 | EP1917966A1 Agents and methods for protection treatment and repair of connective tissue |